Amgen (AMGN) Tops Q2 EPS by 9c; Sees FY11 at Upper End of Guidance Range; Declares First-Ever Dividend
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $417.84 +0.40%
Financial Fact:
Interest and other income, net: 216M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest and other income, net: 216M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Amgen, Inc. (NASDAQ: AMGN) reported Q2 EPS of $1.37, $0.09 better than the analyst estimate of $1.28. Revenue for the quarter came in at $3.96 billion versus the consensus estimate of $3.78 billion.
Now sees FY11 at the upper end of its previously-issued $5-$5.20 range.
The company also declared its first-ever quarterly dividend at 28 cents per share.
Now sees FY11 at the upper end of its previously-issued $5-$5.20 range.
The company also declared its first-ever quarterly dividend at 28 cents per share.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $388 at Guggenheim
- KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
Create E-mail Alert Related Categories
Dividends, Earnings, GuidanceRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
